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ABSTRACT Staphylococcus aureus is a leading cause of life-threatening infections worldwide. The MIC of an antibiotic against
S. aureus, as well as other microbes, is determined by the affinity of the antibiotic for its target in addition to a complex interplay
of many other cellular factors. Identifying nontarget factors impacting resistance to multiple antibiotics could inform the design
of new compounds and lead to more-effective antimicrobial strategies. We examined large collections of transposon insertion
mutants in S. aureus using transposon sequencing (Tn-Seq) to detect transposon mutants with reduced fitness in the presence of
six clinically important antibiotics—ciprofloxacin, daptomycin, gentamicin, linezolid, oxacillin, and vancomycin. This approach
allowed us to assess the relative fitness of manymutants simultaneously within these libraries. We identified pathways/genes
previously known to be involved in resistance to individual antibiotics, including graRS and vraFG (graRS/vraFG),mprF, and
fmtA, validating the approach, and found several to be important across multiple classes of antibiotics. We also identified two
new, previously uncharacterized genes, SAOUHSC_01025 and SAOUHSC_01050, encoding polytopic membrane proteins, as
important in limiting the effectiveness of multiple antibiotics. Machine learning identified similarities in the fitness profiles of
graXRS/vraFG, SAOUHSC_01025, and SAOUHSC_01050mutants upon antibiotic treatment, connecting these genes of un-
known function to modulation of crucial cell envelope properties. Therapeutic strategies that combine a known antibiotic with a
compound that targets these or other intrinsic resistance factors may be of value for enhancing the activity of existing antibiotics
for treating otherwise-resistant S. aureus strains.
IMPORTANCE Bacterial resistance to every major class of antibiotics has emerged, and we are entering a “post-antibiotic era”
where relatively minor infections can lead to serious complications or even death. The utility of an antibiotic for a specific patho-
gen is limited by both intrinsic and acquired factors. Identifying the repertoire of intrinsic resistance factors of an antibiotic for
Staphylococcus aureus, a leading cause of community- and hospital-acquired infections, would inform the design of new drugs
as well as the identification of compounds that enhance the activity of existing drugs. To identify factors that limit the activity of
antibiotics against S. aureus, we used Tn-Seq to simultaneously assess fitness of transposon mutants in every nonessential gene
in the presence of six clinically important antibiotics. This work provides an efficient approach for identifying promising targets
for drugs that can enhance susceptibility or restore sensitivity to existing antibiotics.
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Staphylococcus aureus is a Gram-positive pathogen with a re-markable ability to withstand antibiotics and evade the human
immune system. Many factors, both intrinsic and acquired, have
been shown to contribute to its ability to survive specific antibiotic
stress. For example,methicillin-resistant S. aureus (MRSA) strains
have acquired the mobile staphylococcal cassette chromosome
mec element (SCCmec), encoding a transpeptidase, PBP2A, which
is naturally resistant to -lactams, enabling the organism to make
cross-linked peptidoglycan when the native transpeptidases are
inactivated by the -lactams (1–3). Irrespective of its methicillin
susceptibility status, S. aureus possesses numerous intrinsic fac-
tors that also limit the effectiveness of specific antibiotics (4). In
contrast to acquired resistance factors like PBP2A, intrinsic resis-
tance factors typically play additional roles in normal microbial
physiology. For example, MprF, which modulates cell membrane
charge, was initially identified in Staphylococcus xylosus as a gene
that, when inactivated, increased susceptibility to the cationic
peptide gallidermin (5). The activity of MprF is now known to be
important for protection from other cationic antimicrobial pep-
tides and daptomycin (6–8). TarO, which catalyzes the first step in
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the wall teichoic acid biosynthetic pathway (9), contributes to
-lactam resistance in MRSA, and its deletion results in cell divi-
sion defects and mislocalization of cell wall biosynthetic machin-
ery (10–12). Effective pharmacological inhibition of TarO in
MRSA restores full sensitivity to -lactams even though PBP2A is
present (10, 12), highlighting the potential to mitigate antibiotic
resistance by targeting intrinsic resistance factors. The most at-
tractive candidates for targeting are those factors that hinder the
activity of multiple classes of antibiotics. To identify such candi-
dates, as well as additional factors contributing to the resistance of
specific individual antibiotics, we used the massively parallel ap-
proach of transposon sequencing (Tn-Seq) (13–15) to examine
large pools of S. aureus transposon mutants for fitness defects
upon exposure to multiple classes of antibiotics.
Tn-Seq involves creating large transposon libraries, sequenc-
ing the transposon insertion sites with next-generation sequenc-
ing, and mapping the sequence reads to a reference genome (13,
15). This technique can be used to identify genes that contribute to
fitness in a particular environment or under a particular set of
growth conditions because readsmapping to these genes would be
depleted compared to reads in a control. Depletion of reads in a
gene implies that the mutants have reduced fitness under the test
conditions. Tn-Seq can also be used to identify those insertion
mutants that are highly represented in themutant pool, indicating
that inactivation of those genes increases fitness under the tested
condition.
Tn-Seq has been used previously to identify antibiotic resis-
tance factors for other organisms (16–18) but has not been used to
compare multiple antibiotic classes in Staphylococcus aureus. We
have performedTn-Seq analysis using transposon libraries treated
with six different antibiotics to identify genes with significantly
fewer mapped reads than were seen with an untreated control.
These genes, which we refer to as intrinsic resistance factors, ren-
der the bacteria more sensitive to the antibiotic tested when inac-
tivated. The six antibiotics used in this study, ciprofloxacin, lin-
ezolid, gentamicin, oxacillin, vancomycin, and daptomycin, were
chosen as clinically relevant representatives of antibiotics that tar-
get major pathways: DNA synthesis, protein synthesis, cell wall
synthesis, and membrane stability (Fig. 1A and B) (19–25). In
addition to previously identified factors, we have identified two
hitherto-uncharacterized factors as important intrinsic resistance
factors for multiple antibiotics.
RESULTS AND DISCUSSION
Experimental approach and data analysis. Two different trans-
poson libraries constructed in methicillin-susceptible S. aureus
(MSSA) strain HG003 were used in initial screens for mutants
exhibiting either enhanced resistance or enhanced susceptibility
to an antibiotic (14, 26). The first transposon library was made by
transformation with a temperature-sensitive plasmid and con-
tained insertions in 71,000 unique sites (26). The second library
was made using a phage-based transposition system and included
FIG 1 Intrinsic resistance factors that contribute to antibiotic resistance can be identified by Tn-Seq. (A) The structures of the six different antibiotics used in
the Tn-Seq experiments are shown. (B) The targets of the six antibiotics are shown. (C) A pooled transposon insertion library was grown with or without
antibiotic and subjected to Tn-Seq to quantify the number of sequencing reads thatmap to each insertion location. The black lines in the columns corresponding
to the three genes represent the number of reads mapping to a particular insertion location. In this example, the red gene had similar numbers of reads in the
treated and untreated samples. Therefore, inactivation of this gene does not have an effect on antibiotic susceptibility. The orange gene had a lower number of
reads in the treated sample than in the untreated control. Inactivation of this gene decreases bacterial fitness in the presence of the tested antibiotic. Genes of this
type are known as intrinsic resistance factors. Finally, the blue gene had a higher number of reads in the treated sample than in the untreated control. Inactivation
of this gene increases bacterial fitness in the presence of the test antibiotic.
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transposon insertions in 126,040 unique sites (14). To identify
mutants that exhibit fitness defects that are independent of the
growth condition (and therefore likely to be of value in vivo), the
libraries were treated with six antibiotics at concentrations below
the MIC of the antibiotics and grown in different media for vari-
ous numbers of generations (see Materials and Methods).
Sample preparation and Tn-Seq analysis to determine the lo-
cation of the transposon insertions were performed as described
previously (14, 26, 27). Subsequently, the number of reads map-
ping to a gene under experimental antibiotic treatment conditions
was compared to the number in the untreated control to calculate
the fold change in the number of reads mapping to each gene
(Fig. 1C) as a surrogate measure of the representation of each
mutant in the pool. Data were analyzed as previously described
(14, 17), with one additional step: before comparing the number
of reads/gene using the Mann-Whitney U test, the experimental
condition (antibiotic treatment) was normalized to that of the
untreated control using simulation-based resampling tominimize
differences between the two conditions (28, 29). After all experi-
ments for the two libraries were analyzed independently, P values
and depletion/enrichment ratios for each gene in the presence of
an antibiotic treatment were combined, using Fisher’s method for
P values and the geometric mean of fold changes in the number of
reads mapping to each gene.
Because antibiotics with differing mechanisms of action exert
different degrees of selective pressure on the bacterial population
at fractional MIC levels, it was necessary to tailor the data analysis
approach in a way that enabled comparison across different anti-
biotic treatments. We therefore adjusted the cutoff value for the
fold change in the number of mapped reads/gene for the treated
samples relative to the controls to obtain similar numbers of hits
for each antibiotic. Only genes corresponding to a P value of
0.05 were considered. We used a sliding cutoff value for the
number of reads/gene that resulted in a maximum of 20 genes
being identified as hits for each antibiotic. This sliding fold change
cutoff value ranged from 10-fold (0.1 to 10) for ciprofloxacin to
55-fold for oxacillin. The top genes contributing to susceptibility/
resistance for each antibiotic included genes with fewer as well as
more reads mapping to them in the treated sample than in the
control. The former represent intrinsic resistance factors or im-
pediments to antibiotic inhibition of S. aureus. The latter are also
of interest as they provide information on how antibiotic resis-
tance can arise via gene inactivation.
Intrinsic factors that decrease or increase susceptibility to
antibiotics.Of the genes implicated in antibiotic resistance via the
analysis described above, 80 were unique (see Table S1 in the sup-
plemental material). Among the 20 genes in which transposon
insertion resulted in the greatest change with respect to antibiotic
susceptibility/resistance, we identified fewor none that, whenmu-
tated, provided a fitness advantage upon exposure to ciprofloxa-
cin, daptomycin, linezolid, oxacillin, and vancomycin, with the
notable exception of gentamicin. For gentamicin, half of the mu-
tants exhibited a fitness advantage (Table 1; see also Fig. S1 in the
supplemental material). All of these genes, the absence of which
enhanced fitness in the presence of fractional MIC levels of gen-
tamicin, occur in the oxidative phosphorylation pathway. It is
known that gentamicin and other aminoglycosides rely on the
membrane potential to gain entry into cells (30, 31); disrupting
genes in the oxidative phosphorylation pathway therefore limits
cellular penetration.
This analysis also identifiedmany other genes for which a con-
tribution to resistance/susceptibility to an antibiotic had been ob-
served previously. For example, sigBwas among the hits identified
with oxacillin treatment. Readsmapping to this gene, and to other
components involved in the alternative sigma factor pathway, i.e.,
rsbV and rsbW, were significantly depleted after growth with oxa-
cillin (100-fold depletion in reads/gene for all three genes) (Ta-
ble 1). It has been shown that overexpressing SigB causes cells to
have thicker cell walls, increased transcript levels for penicillin-
binding proteins, and elevated MICs to -lactams and that dele-
TABLE 1 Treatment of a pooled transposon library with six different
antibiotics identified genes that contribute to fitness under antibiotic
stress conditionsa
a Orange rectangles indicate genes for which the numbers of reads due to transposon
insertions were substantially lower than in the control, whereas blue rectangles indicate
genes for which the numbers of reads due to transposon insertions were substantially
higher than in the control. Gray rectangles indicate those genes which were not
identified among the top 20 most affected genes. The top 20 most affected genes for
each antibiotic were identified, and a subset of the 80 unique genes is shown here. The
complete list is shown in Table S1 in the supplemental material. oxa, oxacillin; cip,
ciprofloxacin; gen, gentamicin; lin, linezolid; van, vancomycin; dap, daptomycin.
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tion of sigB renders resistant S. aureus strains more sensitive to
oxacillin (32, 33). Reads for pbp4, which encodes a penicillin-
binding protein involved in secondary cross-linking of pepti-
doglycan and -lactam resistance (34–36), were also found to be
depleted under conditions of oxacillin treatment. Similarly, reads
mapping to all three genes of the vraTSR operon, which encodes a
multicomponent sensing (MCS) system that regulates the cell wall
stress stimulon (37–41), were substantially depleted in the pres-
ence of vancomycin. norA, which encodes an efflux pump that is
known to be involved in ciprofloxacin resistance (42, 43), was also
identified as an important factor under conditions of ciprofloxa-
cin treatment. In addition to these and other known intrinsic re-
sistance factors, we identified 13 hypothetical genes that are im-
portant for resistance to these six antibiotics (see Table S1 in the
supplemental material).
While no inactivated gene altered susceptibility to all six anti-
biotics, we did identify 21 genes that were hits with two or more
antibiotics, and 8 of these were hits withmore than two antibiotics
(see Table S1 in the supplemental material). These 8 genes in-
cluded mprF, ndh, fmtA, components of the graRS and vraFG
(graRS/vraFG) multicomponent sensing system, and two genes of
unknown function, SAOUHSC_01025 and SAOUHSC_01050.
Our ability to detect numerous previously identified resistance
factors using this massively parallel fitness profiling approach
served as a validation of the method. To further confirm the re-
sults and to determine whether these resistance factors were also
important in other S. aureus strains, we examined the fitness of
mutants in genes identified as hits against all six antibiotics under
two or more sets of conditions using an agar spot dilution assay
(Fig. 2; see also Fig. S1 in the supplemental material). Mutants
were chosen based on whether they were identified as hits under
two ormore sets of conditions. In general, the agreement between
Tn-Seq results and the spot dilution assay results was excellent.
Given that the spot dilutions did not involve competition between
thousands of mutants and that the assays were performed at a
single concentration (chosen so that wild-type [WT] growth
would be relatively unaffected; see Materials and Methods) and
involved mutants from different genetic backgrounds (Newman
or USA300 instead of HG003), the high validation rate is remark-
able and supports the choice of the approach described here.
Intrinsic factors that impact multiple classes of antibiotics.
Of the eight genes found to impact multiple classes of antibiotics,
ndh (NADH dehydrogenase) is the only one that, when inacti-
vated, promotes resistance to some antibiotics while promoting
sensitization to others. Ndh is a component of the electron trans-
port chain. The electron transport chain creates a membrane po-
tential, which is required for penetration of gentamicin through
the cell membrane (44).We show here that, in addition to confer-
ring resistance to gentamicin when inactivated, ndh is an intrinsic
resistance factor for oxacillin, linezolid, and ciprofloxacin. ndh is
in the same pathway as several genes that are commonly found to
be inactivated in small colony variants (SCVs), a phenotype cor-
related with persistent infections that are resistant to -lactams as
well as aminoglycosides (45–48). Our data confirmed the impor-
tance of the oxidative phosphorylation pathway in antibiotic re-
sistance, identified new genes of importance, and suggest that a
better understanding of how S. aureus modulates this system
could increase our understanding of antibiotic resistance.
FmtA is a cell surface protein of uncertain function. It was
identified as a factor involved in methicillin resistance and has
since been proposed to act as a carboxypeptidase and a teichoic
acid D-ala esterase (49–51). We did not find that inactivation of
fmtA resulted in increased sensitivity to oxacillin in the Tn-Seq
analysis or in the agar spot dilution assay. In fact, in these tests,
fitness was enhanced compared to that of other mutants under
conditions of oxacillin selection. However, we did observe in-
creased sensitivity of fmtAmutants to daptomycin and vancomy-
cin. The impact of fmtA mutations showed that fmtA met the
threshold for inclusion among the top 20 genes affecting dapto-
mycin resistance but was not among the top 20 for vancomycin
selection. Nevertheless, these data support the idea of an impor-
tant role for FmtA in withstanding cell envelope stress for at least
some classes of antibiotics (52).
MprF catalyzes formation of lyslyphosphatidylglycerol, a
FIG 2 Tn-Seq results were validated by testingmutant fitness in spot dilution
assays. Tn-Seq results and validation for selected genes are shown. ndh encodes
anNADHdehydrogenase involved in oxidative phosphorylation; fmtA is a cell
surface protein of undetermined function; graR is a member of a multicom-
ponent sensing system (MCS); mprF and dltA are members of the regulon of
this MCS. Asterisks indicate those conditions under which the pertinent gene
was among the top 20 hits for that antibiotic. (A) Bar graph depicting fold
change in reads per gene relative to the untreated control for each of the six
antibiotics. As very few insertions in dltAwere present in the untreated control,
changes in fitness could not be detected by Tn-Seq. (B) Bar graph depicting
fitness ofmutant strains inwhich the indicated genes are inactivated compared
to that of theWT. Fitness was assessed by spotting 10-fold dilutions ofWT and
mutant strains on antibiotic plates and comparing the highest dilutions that
resulted in growth (seeMaterials andMethods). Because the data are shownon
a logarithmic scale, the lack of a bar indicates that no change (fold change value
of 1) was observed for that mutant under the relevant treatment condition.
Fitness assessed by spot dilution validated the Tn-Seq results for the list of the
top 20, with the exception of ndh with vancomycin treatment. Strain back-
grounds were USA300 LAC JE2 for the ndh, fmtA, and mprF transposon mu-
tants and Newman for the graR and dltA deletion mutants.
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membrane modification that confers protection against cationic
antibiotics, which are repelled by the increased cell surface posi-
tive charge (6, 8, 53, 54). MprF is also known to contribute to
methicillin resistance in MRSA strains (55), and point mutations
increasing the activity of MprF are a mechanism for daptomycin
resistance (7, 56, 57). In our studies, mprF was found to be an
intrinsic resistance factor for all antibiotics tested, although it oc-
curred among the top 20 for only four of the six (Table 1 and
Fig. 2A). Enhanced susceptibility of mprF mutants to these four
antibiotics was also found in the agar spot dilution assay per-
formed using mutants in the USA300 (MRSA) background
(Fig. 2B) (58). SincemprF inactivation potently promotes sensiti-
zation to daptoymcin, vancomycin, and ciprofloxacin, which are
not rich in positive charges, the positively charged product of
MprF, lysylphosphatidylglycerol, likely plays biophysical roles in
membrane stability or organization. This has been suggested pre-
viously for daptomycin (59, 60).
GraRS/VraFG is themost importantMCS across tested anti-
biotics. Multicomponent sensing systems (MCSs) allow bacteria
to sense and respond to their environments. These systems typi-
cally include a membrane-anchored extracellular sensory domain
fused to an intracellular kinase domain and a separate, cytosolic
response regulator, but they can also include additional elements.
A stimulus sensed by the sensory domain results in a change in the
phosphorylation state of the response regulator, which in turn
modulates the expression of downstream targets (61). S. aureus
contains many multicomponent sensing systems, and we identi-
fied multiple components of three of these systems, agrABCD,
vraTSR, and graXRS/vraFG, among the top hits under conditions
of selection with at least one antibiotic (Table 1; see also Ta-
ble S1 in the supplemental material).
AgrABCD is involved in quorum sensing and regulation of
virulence factors and autolysin expression (62–64). Sequencing
reads from transposon insertions mapping to components agrA,
agrB, and agrD were depleted under conditions of oxacillin or
daptomycin treatment, suggesting that factors regulated by this
MCS are involved in the response to these antibiotics, possibly due
to its regulation of the autolysin lytM and the penicillin-binding
proteins (64–66).While readsmapping to agrCwere also depleted
under these treatment conditions, agrCdid notmeet the threshold
for inclusion in the top 20 hits. The vraTSR system is known for its
crucial role in withstanding vancomycin treatment (38), and all
three components were among the top genes identified under
conditions of vancomycin treatment. This sensing system regu-
lates expression of cell wall biosynthetic genes, and it has also been
implicated in -lactam resistance (37, 39, 67). Although reads
mapping to these genes were also depleted under conditions of
oxacillin treatment, they were not depleted enough to be included
among the top 20 genes contributing to oxacillin resistance.
The single most important MCS across all the six antibiotics
tested is graXRS/vraFG. Four components of this system met our
cutoffs under conditions of gentamicin, daptomycin, and vanco-
mycin treatment (Table 1). Moreover, compared to that of the
wild type, we found the fitness of a graRmutant plated on these
antibiotics to be reduced by 4 to 5 orders of magnitude (Fig. 2B).
This mutant was also sensitive to ciprofloxacin, although less so
than to the other antibiotics tested. The graXRS/vraFG regulon
includes other global regulators such as agr and walKR, and its
function has been linked to numerous stress response and viru-
lence genes (68). However, its best-characterized role is that of
regulation ofmprF and the dlt operon, both of which are involved
in modulating cell surface charge. The dlt operon attaches
D-alanine to lipoteichoic and wall teichoic acids (69), increasing
the positive charge of the cell surface. The dlt pathway has been
shown to modulate resistance to cationic antimicrobial peptides,
aminoglycosides, and other positively charged antibiotics (70).
WhereasmprF was identified as a top hit under several treatment
conditions, transposon insertions in the dlt genes were poorly rep-
resented in the control libraries, because dltmutants exhibit sub-
stantial fitness defects even in the absence of antibiotic selection
and so do not compete well against the other mutants in the li-
brary. However, upon direct testing, we found the fitness of a dltA
mutant plated on three of the six tested antibiotics—vancomycin,
ciprofloxacin, and gentamicin—to be greatly reduced compared
to that of the wild type (Fig. 2B). Binding of the zwitterionic fluo-
roquinolones to the cell surface is known to be antagonized
by calcium or magnesium ions, and perhaps the presence of
D-alanylation of cell wall components is similarly antagonistic
(71). The sensitivity of dltAmutants to vancomycin has been pre-
viously reported and was suggested to be due to increased binding
of vancomycin to the cell surface (72). It was previously shown
that the number of positive charges on aminoglycosides correlates
with activity against the dltAmutant (73), but in our tests, we did
not observe a strong correlation between the number of positive
charges and the fitness of the dltA mutant for different classes of
antibiotics. As D-alanylation of the cell envelope results in pleio-
tropic effects, the fitness of the dltA mutant in the presence of
different antibiotics likely reflects its different cellular roles. Nev-
ertheless, our results suggest that the importance of the graRS/
vraFG MCS can be explained in part by the combined action of
two members of its regulon, dltA and mprF, which modify cell
envelope charge.
Two previously uncharacterized genes are broadly impor-
tant under cell envelope stress conditions. Among the novel
genes identified as hits under one or more sets of treatment con-
ditions, two genes, SAOUHSC_01025 and SAOUHSC_01050, en-
coding polytopic membrane proteins, stood out as particularly
important because both were identified as hits for three of the six
antibiotics: oxacillin, vancomycin, and daptomycin. These genes
are conserved in S. aureus. SAOUHSC_01025 is predicted to have
10 transmembrane domains, with a 93-amino-acid extracellular
domain between helices six and seven, while SAOUHSC_01050 is
predicted to have 3 transmembrane domains and a 191-amino-
acid C-terminal extracellular domain. BLAST and PSI-BLAST
searches performed with SAOUHSC_01025 and SAOUHSC_
01050 did not reveal extensive amino acid identity with proteins
from any other source or of any known function.
Taking advantage of the data generated via the Tn-Seq exper-
iments, we used amachine learning approach to identify the genes
with the fitness profiles (i.e., representing fitness of an inactivation
insertion mutation in that gene under each set of antibiotic con-
ditions) most similar to those of SAOUHSC_01025 and
SAOUHSC_01050 (see Materials and Methods). We first tested
the K-nearest neighbors algorithm by using graX, graS, vraF, or
vraG as the query gene and then searched across all nonessential
genes for those with the most similar fitness profiles for all six
antibiotic selections. For each of these genes, at least two of the
other components of the graXRS/vraFGMCS system were among
the five genes that most closely paralleled their contribution to
fitness in these tests. This result was expected because the individ-
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ual components of the graXRS/vraFG systemwould be expected to
exhibit similar fitness profiles (Fig. 3A).We then applied the algo-
rithm to identify the five genes with the profiles most similar to
those of mutants with insertions in SAOUHSC_01025 and
SAOUHSC_01050. Transposon mutations in SAOUHSC_01025
and SAOUHSC_01050 were most similar in their effect to one
another, and they shared three of four additional nearest neigh-
bors, graS, mprF, and cvfC (Fig. 3B). In addition, graR and vraG
were identified as similar to SAOUHSC_01025 and
SAOUHSC_01050, respectively. These data collectively indicate
that SAOUHSC_01025 and SAOUHSC_01050 are new factors in-
volved in maintaining membrane integrity and withstanding en-
velope stress.
Using the agar spot dilution assay, we tested the fitness of
mutants with transposon insertions in SAOUHSC_01025
(SAOUHSC_01025::Tn) and SAOUHSC_01050 (SAOUHSC_
01050::Tn) against a panel of 12 antibiotics with a greater range of
different targets. In addition to the six antibiotics originally used,
we added moenomycin, targocil, bacitracin, fosfomycin, mupiro-
cin, and rifampin (Fig. 3C; see also Fig. S2 in the supplemental
material). Moenomycin inhibits peptidoglycan synthesis by bind-
ing to the extracellular transglycosylases that polymerize lipid II
(74–76), while bacitracin inhibits the same pathway by binding to
undecaprenylpyrophosphate released during lipid II polymeriza-
tion, thereby preventing lipid II recycling and new lipid II synthe-
sis (77). Fosfomycin inhibits peptidoglycan synthesis by inhibiting
an intracellular enzyme,MurA (78). Targocil inhibits wall teichoic
acid biosynthesis, resulting in depletion of peptidoglycan precur-
sors and, therefore, inhibition of peptidoglycan synthesis (36, 79,
80). Mupirocin inhibits protein translation by targeting an acyl-
tRNA synthetase (81), and rifampin inhibits RNApolymerase (82,
83). Against cell wall-active antibiotics, SAOUHSC_01025::Tn
and SAOUHSC_01050::Tn generally showed large reductions in
fitness, although SAOUHSC_01025::Tn was typically more sus-
ceptible than SAOUHSC_01050::Tn. Moenomycin provides a
striking example of this: the fitness of the SAOUHSC_01025::Tn
FIG 3 Two genes encoding polytopic membrane proteins were found to be important for withstanding antibiotics that target the cell envelope. (A) Schematic
depicting the fitness of a subset of genes upon treatment with different antibiotics. Each column represents an antibiotic, and each row represents a gene. Genes
with related functions, such as the components of the graRS-vraFGMCS, have similar fitness profiles across a panel of antibiotics. Therefore, for any given test
gene, it is possible to identify the five genes with themost similar fitness profiles, and it is inferred that these genes are involved in pathways related to the test gene.
(B) The K-nearest neighbors algorithm predicted that SAOUHSC_01025 and SAOUHSC_01050, which encode polytopic membrane proteins of unknown
function, were most similar to one another and also shared similarity with three of four other identified neighbors. As these neighbors play an important role in
protecting S. aureus from certain classes of antibiotics, we predict that SAOUHSC_01025 and SAOUHSC_01050 are important for cell envelope integrity. (C)
Spot dilution assays showing fitness of inactivation mutants in SAOUHSC_01025 and SAOUHSC_01050 upon plating on the indicated antibiotics compared to
that of theWT (for data representing additional antibiotics, see Fig. S2 in the supplementalmaterial). The first five antibiotics target the cell envelope, and at least
one of the twomutant strains is highly sensitive at an antibiotic concentration that permits growth of theWT at all dilutions. The sixth antibiotic targets protein
translation, and the mutants show a decrease in fitness of only 1 log compared to that of the WT.
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mutant decreased by 4 orders of magnitude whereas the fitness of
the SAOUHSC_01050::Tn mutants did not change. Both the
SAOUHSC_01025::Tn and SAOUHSC_01050::Tnmutants plated
on non-cell wall-related antibiotics showed a more modest re-
duction in fitness. The one exception was that SAOUHSC_
01050::Tn was found to be far more sensitive to gentamicin than
SAOUHSC_01025::Tn, a unique behavior of SAOUHSC_
01050::Tn not observed with any other antibiotic. The greatly de-
creased fitness of both SAOUHSC_01025::Tn and SAOUHSC_
01050::Tnmutants with a wide range of cell wall-active antibiotics
verifies that they play an important role in cell envelope integrity.
There are a number of ways in which SAOUHSC_01025 and
SAOUHSC_01050 could affect cell envelope integrity. Because
these genes have fitness profiles similar to those of graRS/vraFG
and mprF, it is tempting to suggest that their expression is regu-
lated by this MCS. However, this system has been very well stud-
ied, and these two genes have not been identified as members of
the graRS/vraFG regulon (68, 84). Another possibility is that these
genes are part of a parallel cell envelope stress pathway, re-
sponding to stresses similar to those responded to by the graRS/
vraFG MCS. Both genes are predicted to encode proteins with
extracellular domains. It is possible that these extracellular do-
mains could serve a variety of functions, including acting as sen-
sory domains which respond to a small molecule or other metab-
olites produced as a result of cell envelope stress. The possibility
that these proteins could be acting as scaffolding proteins, coor-
dinating cell envelope synthesis or repair, cannot be ruled out. The
heightened sensitivity of SAOUHSC_01050::Tn to gentamicin
suggests that this protein plays a role, directly or indirectly, in
regulating cell membrane potential or cell envelope positive
charge. Futureworkwill provide insight into the cellular functions
of these highly important intrinsic resistance factors.
Conclusion. Treating transposon libraries with subinhibitory
concentrations of antibiotics using a format that involves mas-
sively parallel competition between mutants allows the robust
identification of factors that contribute to resistance. Mutant fit-
ness based on Tn-seq profiles correlated well among multiple ap-
proaches, including assessment of fitness of individual mutants
plated on antibiotics. Previously characterized intrinsic resistance
factors were identified, validating the method, but the use of sat-
urating mutant pools in a massively parallel assay also identified
novel intrinsic resistance factors, including those contributing to
resistance under conditions of treatment with antibiotics in mul-
tiple classes. We also used a machine learning approach to obtain
insights into the physiological roles of genes annotated as hypo-
thetical. Two novel intrinsic resistance factors, SAOUHSC_01025
and SAOUHSC_01050, were found to be important in withstand-
ing cell envelope damage, but elucidation of the mechanism by
which they do so will require further direct characterization.
These or other intrinsic resistance factors may be of considerable
value as targets for the development of small-molecule potentia-
tors that extend the utility of existing and new antibiotics for treat-
ing S. aureus infections.
MATERIALS AND METHODS
Library 1 antibiotic treatment andDNApreparation.Library 1was con-
structed by transformation of a temperature-sensitive plasmid as previ-
ously described (26). Briefly, a 100-l aliquot of this initial S. aureus
HG003 transposon library freezer stock, containing 108 CFU, was used to
inoculate 100 ml of Mueller-Hinton (MH) cation-adjusted broth and
incubated for 15 h at 37°C with shaking at 200 rpm. A 10-l aliquot
(106 CFU) of this input culture was then inoculated into a final volume of
200 l in a 96-well plate broth microdilution format and incubated at
37°C for 8 h, representing approximately 5.5 generations (5 107 CFU/
200l). The 0.5, 0.25, and 0.125MICwells for the library pool were
determined on the basis of the MIC of a small mutant pool (consisting of
10 innocuous transposon mutants). This small pool was used to deter-
mineMICs in order to compensate for resistant mutants potentially pres-
ent in the library pool. The chosen wells (0.5, 0.25, and 0.125) were
then subcultured (3 105 CFU) into a second iteration of serial dilutions
of antibiotics as described above and incubated for 15 h at 37°C, repre-
senting approximately 9 generations (2  108 CFU/200 l). The 0.5,
0.25, and 0.125MIC wells were determined based on the small pool,
and these wells were transferred to 10 ml of brain heart infusion (BHI)
broth and incubated for 4 h at 37°C with shaking at 200 rpm. Biological
replicates were conducted for each growth condition. Genomic DNAwas
harvested using a DNeasy blood and tissue kit (Qiagen, Valencia, CA)
following the manufacturer’s instructions. Library 1 was prepared for
next-generation sequencing using the shearing method as described pre-
viously (27).
Library 2 antibiotic treatment and DNA preparation. Library 2 was
constructed by phage-based transposition of six different transposon con-
structs as previously described (14). Tryptic soy broth (TSB) supple-
mented with 25 mg/liter Ca2 and 12.5 mg/liter Mg2 was used for all
antibiotics except oxacillin, which was tested using cation-adjusted
Mueller-Hinton broth (MHB). For all antibiotics, an untreated control
was prepared in the same media as was used for the tested antibiotic. A
stock of the complete library was thawed and diluted to an optical density
at 600 nm (OD600) of 0.2 and grown to an OD600 of ~0.4 to minimize
changes in library composition prior to treatment. The culture was then
diluted to 4 105CFU/ml and added to 1ml ofmediawith 2 the desired
concentration of the antibiotic to give a final starting inoculum of 2 
105 CFU/ml in 2-ml culture volumes. A 107 CFU/2 ml starting inoculum
was used for vancomycin- and daptomycin-treated samples. Samples
were grown at 37°C and harvested when they reached stationary phase
(~1 109 CFU/2 ml). The samples were treated with 2, 1, 0.5, and
0.25 the MIC of the antibiotic. Then, we identified antibiotic concen-
trations that caused the transposon library to reach stationary phase with
a few hours of delay compared to the untreated control. These antibiotic
concentrations were prepared for sequencing following the protocol de-
scribed by Santiago et al. (14). Samples from at least two of the concen-
trations of library 2 were sent for sequencing. Illumina sequencing was
completed at the Harvard Biopolymers Facility or the Tufts Genomic
DNA Sequencing Core Facility on a HiSeq 2500 sequencing system.
Data analysis of both libraries.We identified datasets from library 2
where readsmapped to approximately 25% to 40%of the TAdinucleotide
sites with hits in the untreated control (with the exception of the vanco-
mycin treatment, which hit 67% of the TA dinucleotide sites hit in the
untreated control). These were processed for further analysis. This per-
centage of decrease was chosen so that we could identify genes with an
increase and a decrease in the number of reads mapping to them. Library
2 contains transposon constructs with outward-facing promoters that can
upregulate proximal genes in addition to the traditional construct which
can only insert into and inactivate genes. For these experiments, we con-
sidered only data from the inactivation constructs. Data for both library 1
and library 2 were analyzed as described previously (14), with the follow-
ing modifications using in-house python scripts. Data from biological
replicates were combined, and before the numbers of reads/gene were
compared using the Mann-Whitney U test, the experimental data were
normalized to the control data using simulation-based resampling (28,
29). Data for each antibiotic treatment from each of the library 1 experi-
ments were then combined with the data from the library 2 experiments
using the geometric mean of the ratios of reads in the antibiotic-treated
sample compared to the control and Fisher’s method for combining cor-
rected P values. Top hits were identified first by filtering for genes with a
Identiﬁcation of Resistance Factors in S. aureus
July/August 2016 Volume 7 Issue 4 e00950-16 ® mbio.asm.org 7
P value of less than 0.05 and then by increasing the fold change cutoff
value by integers until 20 genes or fewer were left.
Spot dilution assays. Identified hits qoxA, qoxB, ndh, fmtA,
SAOUHSC_01025, and SAOUHSC_01050 were validated using trans-
poson mutants from the Nebraska library in the USA300 LAC JE2 back-
ground (58). dltA and graR deletion mutants were tested in methicillin-
susceptible S. aureus (MRSA) strain Newman (17). Agar plates were
prepared with TSB supplemented with Ca2 (25 mg/liter) and Mg2
(12.5 mg/liter) and the six antibiotics at concentrations below the MIC.
Overnight cultures of mutants were diluted 1:100 in fresh TSB and grown
to an OD600 of 1. They were then serially diluted 10-fold, spotted onto an
agar plate, and incubated at 37°C overnight. The concentration of the
antibiotic at which growth of the WT was severely inhibited, showing
growth in only the highest 1 or 2 dilutions on agar plates under these
conditions, was determined. This was considered to be the MIC under
these conditions. The spot dilution assays were then set up using three
different antibiotic concentrations. The concentration closest to the MIC
at which the WT was at most 3 logs more depleted than the control was
used to calculate fitness. This concentration was used so that reduced
fitness of anymutants could be observed. The exception to this was the use
of the MIC for gentamicin to evaluate the resistance of inactivation mu-
tants in the oxidative phosphorylation pathway (see Fig. S1 in the supple-
mental material). Control plates with no antibiotic were set up for all
strains assayed, and under these conditions, the mutant and WT strains
showed equal levels of growth (not shown). Fitness was assessed by deter-
mining the highest dilution for which growth was observed for a mutant
and the WT strain. The highest dilution showing full growth for the mu-
tant was then divided by the highest dilution showing full growth for the
WT to calculate the fitness of themutant compared to that of theWT, and
the results were plotted on a log scale. Those spots that showed hazy
growth indicative of cell lysis, those that showed mixed populations of
colonies of different sizes that suggested the possible presence of suppres-
sors and reduced fitness relative to spots with homogenous colonies, and
those that had fewer than 10 individual colonies were regarded as not
representative of full growth.
Machine learning algorithm optimization. We used the machine
learning algorithm K-nearest nearest neighbors to identify other genes
with similar resistance and sensitization patterns in an unsupervisedman-
ner using the Scikit-learn python library (85). However, because of the
different selective pressures exerted by each antibiotic, the ratio of reads
under the experimental treatment conditions versus the control condi-
tions that map to each gene could not be used as the metric for classifica-
tion. In addition, we wanted to distinguish between the two following
conditions: (i) a ratio change of 0.1 due to 100 reads in the control and 10
reads in the experiment and (ii) a ratio change of 0.1 due to 1,000 reads in
the control and 100 reads in the experiment. For two genes of same length,
option 1 is much less relevant than option 2, as 100 reads/gene and 10
reads/gene both correspond to a gene with a significant fitness defect
whereas a change from1,000 reads/gene to 100 reads/gene ismore likely to
be a significant change. Therefore, we converted the ratios to a more
appropriate fitness measurement value by first choosing a value for the
minimum number of reads per gene that could be considered interesting.
Based on empirical observations, we noticed that essential/fitness-
defective genes tended to have1/10,000 of the total number of reads in
the sample, so the value for any gene with fewer reads mapping to it was
converted to this value. Then, ratios were recalculated. Next, the new
modified ratio was multiplied by the number of reads mapping to that
gene under the treatment conditions and was normalized to the length of
the gene. Genes were ordered from lowest to highest “fitness” level. To
place all the samples on the same scale, the gene with the lowest “fitness”
was given a value of 0, and the gene with the highest “fitness” was given a
value of 1. All other genes were placed in order between these values, in
increments that increased by 1/(total number of genes). This final value,
which we call the “normalized fitness value,” was subsequently used in the
machine learning analysis. Essential genes were removed to reduce bias in
the data set, and the K-nearest neighbors algorithmwas further optimized
by adjusting the Minkowski distance metric to output the genes with the
resistance/sensitization patternsmost similar to those of the test gene.We
identified the five genes (the five nearest neighbors) with the most similar
patterns of “normalized fitness values.”
Data availability. All raw next-generation sequencing data as well as
the python scripts used in the analysis are available on the publically
accessible Harvard Dataverse Network at https://dataverse.harvard.edu/
dataverse/intrinsicresistancefactordata.
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